Hong Kong · Sponsored
Dosing issues with DOACs in Asian real world setting
This content is sponsored. It is intended for healthcare professionals only.
Direct oral anticoagulants (DOACs) are considerably more safe, effective and convenient than vitamin K antagonists (VKA), and require fewer controls and less periodic follow-ups with a more rapid drug onset of effects compared to VKA. As of 2013, DOACs have been preferentially prescribed over warfarin for patients with nonvalvular atrial fibrillation (NVAF).
